Ann K. Donohue - Net Worth and Insider Trading

Ann K. Donohue Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ann K. Donohue owns 1 companies in total, including Cartesian Therapeutics Inc (RNAC) .

Click here to see the complete history of Ann K. Donohue’s form 4 insider trades.

Insider Ownership Summary of Ann K. Donohue

Ticker	Comapny	Transaction Date	Type of Owner
RNAC	Cartesian Therapeutics Inc	2021-05-27	VP Finance

Ann K. Donohue Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ann K. Donohue Ownership Network

Ownership Network List of Ann K. Donohue

No Data

Ownership Network Relation of Ann K. Donohue

Ann K. Donohue Owned Company Details

What does Cartesian Therapeutics Inc do?

Who are the key executives at Cartesian Therapeutics Inc?

Ann K. Donohue is the VP Finance of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .

Cartesian Therapeutics Inc (RNAC) Insider Trades Summary

Over the past 18 months, Ann K. Donohue made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,231,332 shares made by Timothy A Springer , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 2,932 shares made by Carsten Brunn .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 15,516 shares, with a net purchase of 15,516 shares. During the past 18 months, 121 shares of Cartesian Therapeutics Inc (RNAC) were sold and 56,293 shares were bought by its insiders, resulting in a net purchase of 56,172 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cartesian Therapeutics Inc Insider Transactions

No Available Data

Ann K. Donohue Mailing Address

Above is the net worth, insider trading, and ownership report for Ann K. Donohue. You might contact Ann K. Donohue via mailing address: C/o Selecta Biosciences, Inc., 480 Arsenal Way, Building One, Watertown Ma 02472.

Discussions on Ann K. Donohue

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.